Cellosaurus Index : CVCL_0436
Cellosaurus ID : ML-1[HUMANLEUKEMIA]
GDSC1 Name
, GDSC2 Name
: ML-1
CTRP2 Name
: ML1
Cancer Type : thyroid
Dataset : All
Click to show/hide information cards below or download all drug response information.
 Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
---|---|---|---|---|---|
ML-1[HUMANLEUKEMIA] | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 | |
ML-1[HUMANLEUKEMIA] | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 | |
ML-1[HUMANLEUKEMIA] | 965-D2 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | 993-D2 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | A-804598 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | A-83-01 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | AA-COCF3 | CTRP2 | 0.0081 | 270.0000 | |
ML-1[HUMANLEUKEMIA] | abiraterone | CTRP2 | 0.0005 | 17.0000 | |
ML-1[HUMANLEUKEMIA] | ABT737 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | AC55649 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | ACY-1215 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | Afatinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Afuresertib | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | AGI-5198 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | AGK-2 | GDSC2,CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 | |
ML-1[HUMANLEUKEMIA] | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | Alectinib | GDSC1 | 0.0200 | 5.1200 | |
ML-1[HUMANLEUKEMIA] | Alisertib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 | |
ML-1[HUMANLEUKEMIA] | Alpelisib | GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | AM-580 | CTRP2 | 0.0160 | 530.0000 | |
ML-1[HUMANLEUKEMIA] | AMG-319 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | Amuvatinib | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | apicidin | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Apitolisib | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | AR-42 | GDSC1 | 0.0200 | 5.1200 | |
ML-1[HUMANLEUKEMIA] | Ara-G | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | ARRY-520 | GDSC1 | 0.0010 | 0.2560 | |
ML-1[HUMANLEUKEMIA] | AS601245 | GDSC1 | 0.0312 | 8.0000 | |
ML-1[HUMANLEUKEMIA] | AS605240 | GDSC1 | 0.0400 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 | |
ML-1[HUMANLEUKEMIA] | AST-1306 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | AT-406 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | AT-7519 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | AT13148 | GDSC2 | 0.0080 | 8.0000 | |
ML-1[HUMANLEUKEMIA] | AT7867 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | austocystin D | CTRP2 | 0.0011 | 37.0000 | |
ML-1[HUMANLEUKEMIA] | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | avrainvillamide | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Axitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | AZ-3146 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | AZ20 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | AZ6102 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | AZ960 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | azacitidine | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | AZD-7545 | CTRP2 | 0.0023 | 74.0000 | |
ML-1[HUMANLEUKEMIA] | AZD1208 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | AZD1480 | GDSC1 | 0.0098 | 2.5000 | |
ML-1[HUMANLEUKEMIA] | AZD3514 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | AZD3759 | GDSC2 | 0.0010 | 1.0000 | |
ML-1[HUMANLEUKEMIA] | AZD4547 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | AZD5363 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | AZD6094 | GDSC1 | 0.0098 | 2.5000 | |
ML-1[HUMANLEUKEMIA] | AZD6482 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | AZD7762 | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | AZD8055 | GDSC1,CTRP2 | 0.0020 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | AZD8186 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | B02 | CTRP2 | 0.0041 | 8.3000 | |
ML-1[HUMANLEUKEMIA] | BAM7 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BAY ACCi | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 | |
ML-1[HUMANLEUKEMIA] | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 | |
ML-1[HUMANLEUKEMIA] | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 | |
ML-1[HUMANLEUKEMIA] | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 | |
ML-1[HUMANLEUKEMIA] | Belinostat | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | bendamustine | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | betulinic acid | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Bexarotene | GDSC1,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BI-2536 | GDSC2,CTRP2 | 0.0005 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | BIBR-1532 | GDSC2,CTRP2 | 0.0081 | 270.0000 | |
ML-1[HUMANLEUKEMIA] | Bicalutamide | GDSC1,GDSC2 | 0.0040 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | birinapant | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BIX-01294 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | BIX02189 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | Bleomycin | GDSC1 | 0.2500 | 64.0000 | |
ML-1[HUMANLEUKEMIA] | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | Bleomycin (50 uM) | GDSC1 | 0.1953 | 50.0000 | |
ML-1[HUMANLEUKEMIA] | BMS-195614 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BMS-270394 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BMS-345541 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BMS-536924 | GDSC1,GDSC2,CTRP2 | 0.0011 | 37.0000 | |
ML-1[HUMANLEUKEMIA] | BMS-754807 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Bortezomib | GDSC2,CTRP2 | 0.0000 | 0.1300 | |
ML-1[HUMANLEUKEMIA] | Bosutinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K03536150 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K03911514 | CTRP2 | 0.0020 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K09344309 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K09587429 | CTRP2 | 0.0020 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K20514654 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K27188169 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K27188169:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K34222889 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K35604418 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K70511574 | CTRP2 | 0.0041 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K79669418 | CTRP2 | 0.0020 | 17.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD-K99584050 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD1812 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD1835 | CTRP2 | 0.0041 | 130.0000 | |
ML-1[HUMANLEUKEMIA] | BRD4132 | CTRP2 | 0.0049 | 160.0000 | |
ML-1[HUMANLEUKEMIA] | BRD55319 | CTRP2 | 0.0011 | 37.0000 | |
ML-1[HUMANLEUKEMIA] | BRD6340 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | BRD6430 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | BRD8899 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | BRD8958 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | BRD9647 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | BRD9876 | CTRP2 | 0.0041 | 130.0000 | |
ML-1[HUMANLEUKEMIA] | brefeldin A | CTRP2 | 0.0011 | 37.0000 | |
ML-1[HUMANLEUKEMIA] | brivanib | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 | |
ML-1[HUMANLEUKEMIA] | Buparlisib | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | BX-912 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | BX795 | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | C-75 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | C6-ceramide | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Cabozantinib | GDSC1,CTRP2 | 0.0020 | 8.3000 | |
ML-1[HUMANLEUKEMIA] | Camptothecin | GDSC2 | 0.0001 | 0.1000 | |
ML-1[HUMANLEUKEMIA] | canertinib | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | Capivasertib | GDSC1 | 0.1172 | 30.0000 | |
ML-1[HUMANLEUKEMIA] | Carboplatin | CTRP2 | 0.0041 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 | |
ML-1[HUMANLEUKEMIA] | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 | |
ML-1[HUMANLEUKEMIA] | CAY10566 | GDSC1 | 0.0100 | 2.5600 | |
ML-1[HUMANLEUKEMIA] | CAY10576 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | CAY10594 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | CAY10603 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | CAY10618 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | CCT-018159 | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | CCT036477 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | CCT245232 | GDSC1 | 0.0008 | 0.2000 | |
ML-1[HUMANLEUKEMIA] | CCT245467 | GDSC1 | 0.0008 | 0.2000 | |
ML-1[HUMANLEUKEMIA] | CD-1530 | CTRP2 | 0.0041 | 130.0000 | |
ML-1[HUMANLEUKEMIA] | CD-437 | CTRP2 | 0.0011 | 37.0000 | |
ML-1[HUMANLEUKEMIA] | CD532 | GDSC1 | 0.0200 | 5.1200 | |
ML-1[HUMANLEUKEMIA] | Cediranib | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | ceranib-2 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | cerulenin | CTRP2 | 0.0045 | 150.0000 | |
ML-1[HUMANLEUKEMIA] | Cetuximab | GDSC1 | 0.2570 | 65.8000 | |
ML-1[HUMANLEUKEMIA] | Ch-55 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 | |
ML-1[HUMANLEUKEMIA] | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | CHIR-99021 | GDSC1,GDSC2,CTRP2 | 0.0024 | 80.0000 | |
ML-1[HUMANLEUKEMIA] | chlorambucil | CTRP2 | 0.0081 | 270.0000 | |
ML-1[HUMANLEUKEMIA] | CHM-1 | CTRP2 | 0.0005 | 16.0000 | |
ML-1[HUMANLEUKEMIA] | CI-1033 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | CI-1040 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | CI-976 | CTRP2 | 0.0081 | 270.0000 | |
ML-1[HUMANLEUKEMIA] | ciclopirox | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | ciclosporin | CTRP2 | 0.0010 | 17.0000 | |
ML-1[HUMANLEUKEMIA] | CID-5951923 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | CIL41 | CTRP2 | 0.0049 | 160.0000 | |
ML-1[HUMANLEUKEMIA] | CIL55 | CTRP2 | 0.0003 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | CIL55A | CTRP2 | 0.0024 | 80.0000 | |
ML-1[HUMANLEUKEMIA] | CIL56 | CTRP2 | 0.0001 | 2.5000 | |
ML-1[HUMANLEUKEMIA] | CIL70 | CTRP2 | 0.0012 | 40.0000 | |
ML-1[HUMANLEUKEMIA] | Cisplatin | GDSC1 | 0.0117 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | clofarabine | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | COL-3 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Compound 1541A | CTRP2 | 0.0011 | 37.0000 | |
ML-1[HUMANLEUKEMIA] | compound 1B | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | CP466722 | GDSC1 | 0.0625 | 16.0000 | |
ML-1[HUMANLEUKEMIA] | CP724714 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | CPI-613 | GDSC1 | 1.0000 | 256.0000 | |
ML-1[HUMANLEUKEMIA] | CR-1-31B | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Crizotinib | GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 | |
ML-1[HUMANLEUKEMIA] | CRT0105446 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | CRT0105950 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | CRT0160829 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | CUDC-101 | GDSC1 | 0.0200 | 5.1200 | |
ML-1[HUMANLEUKEMIA] | curcumin | CTRP2 | 0.0051 | 170.0000 | |
ML-1[HUMANLEUKEMIA] | CX-5461 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | cyanoquinoline 11 | CTRP2 | 0.0041 | 130.0000 | |
ML-1[HUMANLEUKEMIA] | Cyclophosphamide | GDSC2,CTRP2 | 0.0041 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Cytarabine | GDSC1 | 0.0078 | 2.0000 | |
ML-1[HUMANLEUKEMIA] | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | cytochalasin B | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | CZC24832 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | Dabrafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | Dacarbazine | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Dacinostat | GDSC1 | 0.0040 | 1.0240 | |
ML-1[HUMANLEUKEMIA] | Dactinomycin | GDSC2 | 0.0008 | 0.8000 | |
ML-1[HUMANLEUKEMIA] | Dactolisib | GDSC1,GDSC2,CTRP2 | 0.0003 | 17.0000 | |
ML-1[HUMANLEUKEMIA] | Daporinad | GDSC1,GDSC2,CTRP2 | 0.0000 | 2.0000 | |
ML-1[HUMANLEUKEMIA] | darinaparsin | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Dasatinib | GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | DBeQ | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Decitabine | CTRP2 | 0.0041 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 | |
ML-1[HUMANLEUKEMIA] | dexamethasone | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Dinaciclib | GDSC2 | 0.0010 | 1.0000 | |
ML-1[HUMANLEUKEMIA] | DMOG | GDSC1 | 15.6250 | 4000.0000 | |
ML-1[HUMANLEUKEMIA] | Docetaxel | GDSC1,GDSC2 | 0.0000 | 0.0125 | |
ML-1[HUMANLEUKEMIA] | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 | |
ML-1[HUMANLEUKEMIA] | Doramapimod | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Doxorubicin | GDSC1,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 | |
ML-1[HUMANLEUKEMIA] | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | ELCPK | CTRP2 | 0.0000 | 0.4000 | |
ML-1[HUMANLEUKEMIA] | Elesclomol | GDSC1,GDSC2 | 0.0002 | 0.2000 | |
ML-1[HUMANLEUKEMIA] | elocalcitol | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Embelin | GDSC1 | 0.1250 | 32.0000 | |
ML-1[HUMANLEUKEMIA] | Entinostat | GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Entospletinib | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | Enzastaurin | GDSC1 | 0.0400 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 | |
ML-1[HUMANLEUKEMIA] | Epirubicin | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | Epothilone B | GDSC1 | 0.0001 | 0.0320 | |
ML-1[HUMANLEUKEMIA] | EPZ004777 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | EPZ5676 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | erastin | CTRP2 | 0.0041 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Erlotinib | GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 | |
ML-1[HUMANLEUKEMIA] | etomoxir | CTRP2 | 0.0090 | 300.0000 | |
ML-1[HUMANLEUKEMIA] | Etoposide | GDSC1,CTRP2 | 0.0009 | 28.0000 | |
ML-1[HUMANLEUKEMIA] | ETP-45835 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | ETP-46464 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Fedratinib | GDSC1,CTRP2 | 0.0011 | 18.0000 | |
ML-1[HUMANLEUKEMIA] | FH535 | GDSC1 | 0.1250 | 32.0000 | |
ML-1[HUMANLEUKEMIA] | fingolimod | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Flavopiridol | GDSC1 | 0.0100 | 2.5600 | |
ML-1[HUMANLEUKEMIA] | fluorouracil | CTRP2 | 0.0041 | 130.0000 | |
ML-1[HUMANLEUKEMIA] | fluvastatin | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | FMK | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | Foretinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | FQI-1 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | FQI-2 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | FR-180204 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | FS106 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | FS112 | GDSC1 | 0.0195 | 5.0000 | |
ML-1[HUMANLEUKEMIA] | FTI-277 | GDSC1 | 0.0040 | 1.0240 | |
ML-1[HUMANLEUKEMIA] | FTY-720 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | Fulvestrant | GDSC2 | 0.0010 | 1.0000 | |
ML-1[HUMANLEUKEMIA] | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 | |
ML-1[HUMANLEUKEMIA] | FY012 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | FY026 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | FY069 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | GANT-61 | CTRP2 | 0.0041 | 17.0000 | |
ML-1[HUMANLEUKEMIA] | GDC-0879 | CTRP2 | 0.0020 | 4.2000 | |
ML-1[HUMANLEUKEMIA] | GDC0810 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | Gefitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Gemcitabine | GDSC1,GDSC2,CTRP2 | 0.0002 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | GMX-1778 | CTRP2 | 0.0000 | 0.2900 | |
ML-1[HUMANLEUKEMIA] | GNE-317 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | gossypol | CTRP2 | 0.0011 | 18.0000 | |
ML-1[HUMANLEUKEMIA] | GSK-J4 | GDSC1 | 0.1172 | 30.0000 | |
ML-1[HUMANLEUKEMIA] | GSK1059615 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | GSK1070916 | GDSC1 | 0.0100 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 5.0000 | |
ML-1[HUMANLEUKEMIA] | GSK2578215A | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | GSK2606414 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | GSK2636771 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | GSK269962A | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | GSK343 | GDSC2 | 0.0010 | 1.0000 | |
ML-1[HUMANLEUKEMIA] | GSK4112 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | GSK429286A | GDSC1 | 0.0400 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | GSK461364 | CTRP2 | 0.0020 | 17.0000 | |
ML-1[HUMANLEUKEMIA] | GSK591 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | GSK650394 | GDSC1 | 0.0625 | 16.0000 | |
ML-1[HUMANLEUKEMIA] | GSK690693 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | GW-2580 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | GW-405833 | CTRP2 | 0.0041 | 130.0000 | |
ML-1[HUMANLEUKEMIA] | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 | |
ML-1[HUMANLEUKEMIA] | HBX-41108 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | HC-067047 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 | |
ML-1[HUMANLEUKEMIA] | HLI 373 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | hyperforin | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | I-BET-762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | I-BET151 | GDSC1,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | I-BRD9 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | I-CBP112 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | IAP_5620 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | IAP_7638 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | Ibrutinib | GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | IC-87114 | GDSC1,CTRP2 | 0.0020 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | ICL1100013 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | Idelalisib | GDSC1,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | ifosfamide | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Imatinib | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | IMD-0354 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | importazole | CTRP2 | 0.0061 | 200.0000 | |
ML-1[HUMANLEUKEMIA] | IOX2 | GDSC1,GDSC2 | 0.0004 | 0.5000 | |
ML-1[HUMANLEUKEMIA] | IPA-3 | GDSC1 | 0.1250 | 32.0000 | |
ML-1[HUMANLEUKEMIA] | Ipatasertib | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | IPR-456 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Irinotecan | GDSC2 | 0.0050 | 5.0000 | |
ML-1[HUMANLEUKEMIA] | isoevodiamine | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | isonicotinohydroxamic acid | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | ISOX | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 | |
ML-1[HUMANLEUKEMIA] | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 | |
ML-1[HUMANLEUKEMIA] | itraconazole | CTRP2 | 0.0005 | 17.0000 | |
ML-1[HUMANLEUKEMIA] | IU1 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | IWP-2 | GDSC2 | 0.0010 | 1.0000 | |
ML-1[HUMANLEUKEMIA] | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | JNK-9L | GDSC1 | 0.0200 | 5.1200 | |
ML-1[HUMANLEUKEMIA] | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 | |
ML-1[HUMANLEUKEMIA] | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 | |
ML-1[HUMANLEUKEMIA] | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 | |
ML-1[HUMANLEUKEMIA] | JQ1 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | JQ12 | GDSC1 | 0.0200 | 5.1200 | |
ML-1[HUMANLEUKEMIA] | JW-480 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | JW-55 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | JW-74 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | KH-CB19 | CTRP2 | 0.0005 | 17.0000 | |
ML-1[HUMANLEUKEMIA] | KHS101 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Ki8751 | CTRP2 | 0.0020 | 17.0000 | |
ML-1[HUMANLEUKEMIA] | KIN001-042 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | KIN001-236 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | KIN001-244 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | KIN001-260 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | KIN001-266 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | KIN001-270 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | Ko-143 | CTRP2 | 0.0041 | 130.0000 | |
ML-1[HUMANLEUKEMIA] | Kobe2602 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | KPT185 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | KU 0060648 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | KU-0063794 | CTRP2 | 0.0020 | 4.2000 | |
ML-1[HUMANLEUKEMIA] | KU-55933 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | KU-60019 | GDSC1,CTRP2 | 0.0081 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | KW-2449 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | KX2-391 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | L-685458 | CTRP2 | 0.0011 | 37.0000 | |
ML-1[HUMANLEUKEMIA] | Lapatinib | GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | LBH-589 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | LCL161 | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | LDN-193189 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | LE-135 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Leflunomide | GDSC2 | 0.1001 | 100.0000 | |
ML-1[HUMANLEUKEMIA] | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | Lenvatinib | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | leptomycin B | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 | |
ML-1[HUMANLEUKEMIA] | LFM-A13 | GDSC1 | 0.0625 | 16.0000 | |
ML-1[HUMANLEUKEMIA] | LGK974 | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | Linifanib | GDSC1,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Linsitinib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | LJI308 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | lomeguatrib | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | lovastatin acid | CTRP2 | 0.0081 | 130.0000 | |
ML-1[HUMANLEUKEMIA] | LRRK2-IN-1 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Luminespib | GDSC1,GDSC2 | 0.0003 | 0.2560 | |
ML-1[HUMANLEUKEMIA] | LY2109761 | GDSC2 | 0.0050 | 5.0000 | |
ML-1[HUMANLEUKEMIA] | manumycin A | CTRP2 | 0.0009 | 30.0000 | |
ML-1[HUMANLEUKEMIA] | marinopyrrole A | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Masitinib | GDSC1,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Mdivi-1 | CTRP2 | 0.0020 | 8.3000 | |
ML-1[HUMANLEUKEMIA] | Merck60 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 | |
ML-1[HUMANLEUKEMIA] | Methotrexate | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | methylstat | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | MG-132 | GDSC2 | 0.0040 | 4.0000 | |
ML-1[HUMANLEUKEMIA] | MGCD-265 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | MI-1 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Midostaurin | GDSC1 | 0.0020 | 0.5120 | |
ML-1[HUMANLEUKEMIA] | MIM1 | GDSC1 | 0.1562 | 40.0000 | |
ML-1[HUMANLEUKEMIA] | MIRA-1 | GDSC2,CTRP2 | 0.0020 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 | |
ML-1[HUMANLEUKEMIA] | mitomycin | CTRP2 | 0.0015 | 50.0000 | |
ML-1[HUMANLEUKEMIA] | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 | |
ML-1[HUMANLEUKEMIA] | MK-0752 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | MK-1775 | GDSC2,CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | MK-2206 | GDSC2,CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | MK-8776 | GDSC2 | 0.0050 | 5.0000 | |
ML-1[HUMANLEUKEMIA] | ML006 | CTRP2 | 0.0320 | 530.0000 | |
ML-1[HUMANLEUKEMIA] | ML030 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | ML050 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | ML162 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | ML203 | CTRP2 | 0.0011 | 37.0000 | |
ML-1[HUMANLEUKEMIA] | ML210 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | ML239 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | ML258 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | ML311 | CTRP2 | 0.0010 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | ML320 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | ML323 | GDSC2 | 0.0200 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 | |
ML-1[HUMANLEUKEMIA] | MLN2238 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | MN-64 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | momelotinib | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | myricetin | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 | |
ML-1[HUMANLEUKEMIA] | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | narciclasine | CTRP2 | 0.0041 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Navitoclax | GDSC1,GDSC2,CTRP2 | 0.0010 | 2.0000 | |
ML-1[HUMANLEUKEMIA] | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 | |
ML-1[HUMANLEUKEMIA] | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 | |
ML-1[HUMANLEUKEMIA] | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Nelarabine | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | neratinib | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | NG-25 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | niclosamide | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Nilotinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | nintedanib | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Niraparib | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | NPC-26 | CTRP2 | 0.0012 | 40.0000 | |
ML-1[HUMANLEUKEMIA] | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | NSC 74859 | CTRP2 | 0.0160 | 530.0000 | |
ML-1[HUMANLEUKEMIA] | NSC-207895 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | NSC-87877 | GDSC1 | 0.0625 | 16.0000 | |
ML-1[HUMANLEUKEMIA] | NSC23766 | CTRP2 | 0.0160 | 530.0000 | |
ML-1[HUMANLEUKEMIA] | NSC30930 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | NSC319726 | GDSC1 | 0.0010 | 0.2560 | |
ML-1[HUMANLEUKEMIA] | NSC48300 | CTRP2 | 0.0020 | 17.0000 | |
ML-1[HUMANLEUKEMIA] | NSC632839 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | NSC95397 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | Nutlin-3a | GDSC1,GDSC2,CTRP2 | 0.0045 | 150.0000 | |
ML-1[HUMANLEUKEMIA] | NVP-231 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | NVP-ADW742 | GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | NVP-TAE684 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Obatoclax Mesylate | GDSC1,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | OF-1 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | Olaparib | GDSC1,GDSC2,CTRP2 | 0.0045 | 150.0000 | |
ML-1[HUMANLEUKEMIA] | oligomycin A | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Omipalisib | GDSC1 | 0.0005 | 0.1280 | |
ML-1[HUMANLEUKEMIA] | OSI-027 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | OSI-930 | GDSC1,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Osimertinib | GDSC2 | 0.0010 | 1.0000 | |
ML-1[HUMANLEUKEMIA] | OSU-03012 | GDSC1 | 0.0625 | 16.0000 | |
ML-1[HUMANLEUKEMIA] | OTX015 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | ouabain | CTRP2 | 0.0081 | 270.0000 | |
ML-1[HUMANLEUKEMIA] | Oxaliplatin | GDSC2,CTRP2 | 0.0100 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | P22077 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | PAC-1 | GDSC1 | 0.0100 | 2.5600 | |
ML-1[HUMANLEUKEMIA] | Paclitaxel | GDSC2,CTRP2 | 0.0001 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Palbociclib | GDSC2 | 0.0040 | 4.0000 | |
ML-1[HUMANLEUKEMIA] | palmostatin B | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | pandacostat | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Panobinostat | GDSC1 | 0.0040 | 1.0240 | |
ML-1[HUMANLEUKEMIA] | parbendazole | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | PARP_0108 | GDSC1 | 0.0098 | 2.5000 | |
ML-1[HUMANLEUKEMIA] | PARP_9482 | GDSC1 | 0.0098 | 2.5000 | |
ML-1[HUMANLEUKEMIA] | PARP_9495 | GDSC1 | 0.0098 | 2.5000 | |
ML-1[HUMANLEUKEMIA] | Parthenolide | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Pazopanib | GDSC1,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | PCI-34051 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | PD 153035 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | PD0325901 | GDSC1,GDSC2 | 0.0025 | 2.5000 | |
ML-1[HUMANLEUKEMIA] | PD173074 | GDSC1,GDSC2 | 0.0078 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | PD318088 | CTRP2 | 0.0081 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Pelitinib | GDSC1 | 0.0098 | 2.5000 | |
ML-1[HUMANLEUKEMIA] | Pemetrexed | GDSC1 | 0.0100 | 2.5600 | |
ML-1[HUMANLEUKEMIA] | Pevonedistat | GDSC1,GDSC2,CTRP2 | 0.0011 | 37.0000 | |
ML-1[HUMANLEUKEMIA] | PF-00299804 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | PF-184 | CTRP2 | 0.0041 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | PF-4708671 | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | PF-562271 | GDSC1 | 0.0100 | 2.5600 | |
ML-1[HUMANLEUKEMIA] | PF-573228 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | PF-750 | CTRP2 | 0.0081 | 270.0000 | |
ML-1[HUMANLEUKEMIA] | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | PHA-793887 | GDSC1,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Phenformin | GDSC1 | 15.6250 | 4000.0000 | |
ML-1[HUMANLEUKEMIA] | phloretin | CTRP2 | 0.0180 | 590.0000 | |
ML-1[HUMANLEUKEMIA] | PI-103 | GDSC1,CTRP2 | 0.0011 | 37.0000 | |
ML-1[HUMANLEUKEMIA] | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | Pictilisib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 | |
ML-1[HUMANLEUKEMIA] | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | PIK-93 | GDSC1,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Pilaralisib | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | Piperlongumine | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | pitstop2 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | PL-DI | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Platin | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | pluripotin | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | PLX-4032 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | PLX-4720 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Ponatinib | GDSC1 | 0.0020 | 0.5120 | |
ML-1[HUMANLEUKEMIA] | PRIMA-1 | CTRP2 | 0.0051 | 83.0000 | |
ML-1[HUMANLEUKEMIA] | PRIMA-1MET | GDSC2,CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 | |
ML-1[HUMANLEUKEMIA] | procarbazine | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | prochlorperazine | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | PRT062607 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | purmorphamine | CTRP2 | 0.0046 | 150.0000 | |
ML-1[HUMANLEUKEMIA] | PX-12 | CTRP2 | 0.0030 | 100.0000 | |
ML-1[HUMANLEUKEMIA] | PYR-41 | CTRP2 | 0.0041 | 8.3000 | |
ML-1[HUMANLEUKEMIA] | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Pyridostatin | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | QL-X-138 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | QS11 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | Quizartinib | GDSC1,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | R428 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | RAF265 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Rapamycin | GDSC2,CTRP2 | 0.0001 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | Regorafenib | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Repligen 136 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | RG-108 | CTRP2 | 0.0081 | 270.0000 | |
ML-1[HUMANLEUKEMIA] | Ribociclib | GDSC2 | 0.0020 | 2.0000 | |
ML-1[HUMANLEUKEMIA] | rigosertib | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | RITA | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | rTRAIL | GDSC1 | 0.0004 | 0.1000 | |
ML-1[HUMANLEUKEMIA] | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 | |
ML-1[HUMANLEUKEMIA] | Ruxolitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | RVX-208 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | Sabutoclax | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | salermide | CTRP2 | 0.0120 | 400.0000 | |
ML-1[HUMANLEUKEMIA] | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 | |
ML-1[HUMANLEUKEMIA] | Sapitinib | GDSC2 | 0.0050 | 5.0000 | |
ML-1[HUMANLEUKEMIA] | Saracatinib | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Savolitinib | GDSC2 | 0.0010 | 1.0000 | |
ML-1[HUMANLEUKEMIA] | SB-225002 | CTRP2 | 0.0011 | 37.0000 | |
ML-1[HUMANLEUKEMIA] | SB-431542 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | SB-525334 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | SB-743921 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | SB505124 | GDSC1,GDSC2 | 0.0100 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | SB52334 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | SB590885 | GDSC2 | 0.0050 | 5.0000 | |
ML-1[HUMANLEUKEMIA] | SCH-529074 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | SCH-79797 | CTRP2 | 0.0023 | 37.0000 | |
ML-1[HUMANLEUKEMIA] | SCH772984 | GDSC2 | 0.0050 | 5.0000 | |
ML-1[HUMANLEUKEMIA] | Selisistat | GDSC1,CTRP2 | 0.0024 | 80.0000 | |
ML-1[HUMANLEUKEMIA] | Selumetinib | GDSC1,GDSC2,CTRP2 | 0.0081 | 270.0000 | |
ML-1[HUMANLEUKEMIA] | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 | |
ML-1[HUMANLEUKEMIA] | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 | |
ML-1[HUMANLEUKEMIA] | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 | |
ML-1[HUMANLEUKEMIA] | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 | |
ML-1[HUMANLEUKEMIA] | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 | |
ML-1[HUMANLEUKEMIA] | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 | |
ML-1[HUMANLEUKEMIA] | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 | |
ML-1[HUMANLEUKEMIA] | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 | |
ML-1[HUMANLEUKEMIA] | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 | |
ML-1[HUMANLEUKEMIA] | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 | |
ML-1[HUMANLEUKEMIA] | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 | |
ML-1[HUMANLEUKEMIA] | semagacestat | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Sepantronium bromide | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | Serdemetan | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 | |
ML-1[HUMANLEUKEMIA] | SGX-523 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Shikonin | GDSC1 | 0.0625 | 16.0000 | |
ML-1[HUMANLEUKEMIA] | SID 26681509 | CTRP2 | 0.0090 | 300.0000 | |
ML-1[HUMANLEUKEMIA] | sildenafil | CTRP2 | 0.0160 | 530.0000 | |
ML-1[HUMANLEUKEMIA] | silmitasertib | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | simvastatin | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 | |
ML-1[HUMANLEUKEMIA] | SJ-172550 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | SKI-II | CTRP2 | 0.0041 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | SL0101 | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | SMER-3 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | SN-38 | GDSC1,GDSC2 | 0.0002 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | SNS-032 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | SNX-2112 | GDSC1,CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 | |
ML-1[HUMANLEUKEMIA] | Sorafenib | GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | sotrastaurin | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | spautin-1 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Sphingosine Kinase 1 Inhibitor II | GDSC1,CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | SR-II-138A | CTRP2 | 0.0041 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | SR1001 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Staurosporine | GDSC2 | 0.0078 | 2.0000 | |
ML-1[HUMANLEUKEMIA] | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | STF-31 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | STF-62247 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | SU11274 | GDSC1,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Sunitinib | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | T-5345967 | CTRP2 | 0.0160 | 530.0000 | |
ML-1[HUMANLEUKEMIA] | T0901317 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | tacedinaline | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | tacrolimus | CTRP2 | 0.0023 | 74.0000 | |
ML-1[HUMANLEUKEMIA] | TAK-715 | GDSC1 | 0.0400 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | tamatinib | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Tamoxifen | GDSC1,GDSC2,CTRP2 | 0.0030 | 100.0000 | |
ML-1[HUMANLEUKEMIA] | tandutinib | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Tanespimycin | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 | |
ML-1[HUMANLEUKEMIA] | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Taselisib | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | Telomerase Inhibitor IX | GDSC2,CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Temozolomide | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Temsirolimus | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Teniposide | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | TG-100-115 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | TGX221 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Thapsigargin | GDSC1 | 0.0020 | 0.5120 | |
ML-1[HUMANLEUKEMIA] | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 | |
ML-1[HUMANLEUKEMIA] | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | tigecycline | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Tipifarnib | GDSC1 | 0.0625 | 16.0000 | |
ML-1[HUMANLEUKEMIA] | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | tipifarnib-P2 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Tivozanib | GDSC1,CTRP2 | 0.0005 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | TL-1-85 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | TL-2-105 | GDSC1 | 0.0200 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | Topotecan | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Torin 2 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | tosedostat | CTRP2 | 0.0081 | 270.0000 | |
ML-1[HUMANLEUKEMIA] | Tozasertib | GDSC2 | 0.0050 | 5.0000 | |
ML-1[HUMANLEUKEMIA] | TPCA-1 | GDSC1,CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 | |
ML-1[HUMANLEUKEMIA] | Tretinoin | GDSC1,GDSC2,CTRP2 | 0.0041 | 130.0000 | |
ML-1[HUMANLEUKEMIA] | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 | |
ML-1[HUMANLEUKEMIA] | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 | |
ML-1[HUMANLEUKEMIA] | Trichostatin A | GDSC1 | 0.0040 | 1.0240 | |
ML-1[HUMANLEUKEMIA] | trifluoperazine | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | triptolide | CTRP2 | 0.0000 | 0.2900 | |
ML-1[HUMANLEUKEMIA] | Tubastatin A | GDSC1,CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | TW 37 | GDSC1,CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | TWS119 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | Ulixertinib | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | UNC0321 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | UNC0638 | GDSC1,CTRP2 | 0.0010 | 40.0000 | |
ML-1[HUMANLEUKEMIA] | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | UNC0642 | GDSC1 | 0.0020 | 0.5000 | |
ML-1[HUMANLEUKEMIA] | UNC1215 | GDSC1 | 0.0039 | 1.0000 | |
ML-1[HUMANLEUKEMIA] | Uprosertib | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | valdecoxib | CTRP2 | 0.0180 | 600.0000 | |
ML-1[HUMANLEUKEMIA] | vandetanib | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | VE-822 | GDSC2 | 0.0050 | 5.0000 | |
ML-1[HUMANLEUKEMIA] | VE821 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | Veliparib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Venetoclax | GDSC2,CTRP2 | 0.0010 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Venotoclax | GDSC1 | 0.0010 | 0.2560 | |
ML-1[HUMANLEUKEMIA] | VER-155008 | CTRP2 | 0.0011 | 37.0000 | |
ML-1[HUMANLEUKEMIA] | Vinblastine | GDSC1 | 0.0004 | 0.1000 | |
ML-1[HUMANLEUKEMIA] | Vincristine | CTRP2 | 0.0041 | 130.0000 | |
ML-1[HUMANLEUKEMIA] | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 | |
ML-1[HUMANLEUKEMIA] | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | VNLG-124 | GDSC1 | 0.0200 | 5.1200 | |
ML-1[HUMANLEUKEMIA] | vorapaxar | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Vorinostat | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | Voxtalisib | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | VU0155056 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | VX-702 | GDSC1 | 0.0078 | 2.0000 | |
ML-1[HUMANLEUKEMIA] | WAY-362450 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | WEHI-539 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | WHI-P97 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | WIKI4 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | Wnt-C59 | GDSC1,GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | WP1130 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | WYE-125132 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | WZ3105 | GDSC1 | 0.0050 | 1.2800 | |
ML-1[HUMANLEUKEMIA] | WZ4002 | CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | WZ4003 | GDSC2 | 0.0100 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | WZ8040 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | XAV939 | GDSC1,GDSC2 | 0.0050 | 5.0000 | |
ML-1[HUMANLEUKEMIA] | XL765 | CTRP2 | 0.0020 | 66.0000 | |
ML-1[HUMANLEUKEMIA] | XMD13-2 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | XMD14-99 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | XMD15-27 | GDSC1 | 0.0400 | 10.2400 | |
ML-1[HUMANLEUKEMIA] | Y-39983 | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | YK-4-279 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 | |
ML-1[HUMANLEUKEMIA] | YM201636 | GDSC1 | 0.0200 | 5.1200 | |
ML-1[HUMANLEUKEMIA] | zebularine | CTRP2 | 0.0180 | 590.0000 | |
ML-1[HUMANLEUKEMIA] | Zibotentan | GDSC1 | 0.0781 | 20.0000 | |
ML-1[HUMANLEUKEMIA] | ZL049 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | ZL109 | GDSC1 | 0.0391 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | ZM447439 | GDSC1,GDSC2 | 0.0078 | 10.0000 | |
ML-1[HUMANLEUKEMIA] | ZSTK474 | GDSC1,CTRP2 | 0.0020 | 66.0000 |